首页> 美国卫生研究院文献>International Scholarly Research Notices >Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital Addis Ababa Ethiopia
【2h】

Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital Addis Ababa Ethiopia

机译:埃塞俄比亚亚的斯亚贝巴Zewditu纪念医院开展HAART治疗后感染HIV的患者的生存预测指标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction. ART has improved the survival of HIV-infected patients. However, patients in resource-poor countries have higher mortality rates, particularly the first months after initiating ART. In this study we tried to determine the survival factors in HIV-infected patients treated with HAART in Zewditu Memorial Hospital. Methods. A retrospective cohort study was conducted from 2008 to 2012. All HIV-infected patients above the age of 14 took first line ART. Data were collected, entered, and analyzed using Epi Info 7 and SPSS Version 20. Life table was used to estimate mortality after initiation of ART, and Kaplan-Meier was used to compare survival curves. Cox proportional hazards model was used to assess the predictors of mortality. Results. The incidence of mortality was 3.8/100 person-years. Independent predictors of mortality were WHO clinical stages 3-4 (HR = 2.39 at 95% CI (1.26, 5.31)), anemia (hemoglobin level < 10 gm/dL (HR = 5.54 at 95% CI (2.58, 11.86)). Conclusion. Incidence of mortality was found relatively low, majority of deaths occurring within 3 months of starting ART. WHO stages 3-4, anemia (hemoglobin count < 10 gm/dL), and past TB coinfection were the main predictors of mortality. The underlying causes for early death in patients presenting at late stages should be investigated.
机译:介绍。 ART已提高了HIV感染患者的生存率。但是,资源贫乏国家的患者死亡率较高,尤其是开始抗病毒治疗后的头几个月。在这项研究中,我们试图确定Zewditu纪念医院接受HAART治疗的HIV感染患者的生存因素。方法。从2008年至2012年进行了一项回顾性队列研究。所有14岁以上的HIV感染患者均接受一线抗病毒治疗。使用Epi Info 7和SPSS Version 20收集,输入和分析数据。生命表用于评估ART手术后的死亡率,Kaplan-Meier用于比较生存曲线。使用Cox比例风险模型评估死亡率的预测因子。结果。死亡率为3.8 / 100人年。死亡率的独立预测因子是WHO临床3-4阶段(95%CI时HR = 2.39(1.26,5.31)),贫血(血红蛋白水平<10μgm/ dL(95%CI时HR = 5.54(2.58,11.86))。结论:发现死亡率较低,大多数死亡发生在开始ART的3个月内; WHO 3-4级,贫血(血红蛋白计数<10μgm/ dL)和结核合并感染是死亡率的主要预测指标。应调查晚期患者的早期死亡的根本原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号